Drug Type Small molecule drug |
Synonyms ON 108600, ON108600 |
Target |
Action inhibitors |
Mechanism CK2 inhibitors(Casein kinase II inhibitors), TNIK inhibitors(TRAF2 and NCK-interacting protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Triple Negative Breast Cancer | Preclinical | United States | 01 Aug 2015 | |
| Triple Negative Breast Cancer | Preclinical | United States | 01 Aug 2015 |





